Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Malignant Melanoma

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 166 articles:
HTML format



Single Articles


    June 2020
  1. HAYWOOD S, Garioch J, Ramaiya A, Moncrieff M, et al
    Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy.
    Ann Surg Oncol. 2020 Jun 15. pii: 10.1245/s10434-020-08713.
    PubMed     Abstract available


  2. MORRISON S, Han D
    ASO Author Reflections: Sentinel Lymph Node Biopsy is Prognostic in the Thickest Melanoma Cases and Should be Performed for Thick Melanomas.
    Ann Surg Oncol. 2020 Jun 12. pii: 10.1245/s10434-020-08725.
    PubMed    


  3. LEE AY, Friedman EB, Sun J, Potdar A, et al
    The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.
    Ann Surg Oncol. 2020 Jun 11. pii: 10.1245/s10434-020-08708.
    PubMed     Abstract available


  4. HU Y, Brady MS
    ASO Author Reflections: Role of Sentinel Lymph Node Biopsy in T1b Melanoma.
    Ann Surg Oncol. 2020 Jun 11. pii: 10.1245/s10434-020-08564.
    PubMed    


  5. HAN D, Han G, Duque MT, Morrison S, et al
    Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick Melanomas.
    Ann Surg Oncol. 2020 Jun 10. pii: 10.1245/s10434-020-08706.
    PubMed     Abstract available


  6. KARAKOUSIS GC, Faries MB
    Sentinel Lymph Node Biopsy for Melanoma: Buggy Whip or Roller Bearing?
    Ann Surg Oncol. 2020 Jun 9. pii: 10.1245/s10434-020-08567.
    PubMed    


  7. HU Y, Briggs A, Gennarelli RL, Bartlett EK, et al
    Sentinel Lymph Node Biopsy for T1b Melanoma: Balancing Prognostic Value and Cost.
    Ann Surg Oncol. 2020 Jun 8. pii: 10.1245/s10434-020-08558.
    PubMed     Abstract available


  8. MONCRIEFF MD, Sharma RA, Gathura E, Heaton MJ, et al
    Improved Perioperative Seroma and Complication Rates Following the Application of a 2-Layer Negative Pressure Wound Therapy System After Inguinal Lymphadenectomy for Metastatic Cutaneous Melanoma.
    Ann Surg Oncol. 2020 Jun 5. pii: 10.1245/s10434-020-08513.
    PubMed     Abstract available


  9. LEVINE LS, Mahuron KM, Tsai KK, Wu C, et al
    Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
    Ann Surg Oncol. 2020 Jun 2. pii: 10.1245/s10434-020-08648.
    PubMed     Abstract available


  10. MAHURON KM, Levine LS, Daud AI
    ASO Author Reflections: Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
    Ann Surg Oncol. 2020 Jun 2. pii: 10.1245/s10434-020-08672.
    PubMed    


    May 2020
  11. RAUWERDINK DJW, Molina G, Frederick DT, Sharova T, et al
    Mixed Response to Immunotherapy in Patients with Metastatic Melanoma.
    Ann Surg Oncol. 2020 May 29. pii: 10.1245/s10434-020-08657.
    PubMed     Abstract available


  12. NEUWIRTH MG, Bartlett EK
    Timing Is Everything: Could Surveillance Imaging Intensity Influence Survival in High-Risk Melanoma?
    Ann Surg Oncol. 2020 May 28. pii: 10.1245/s10434-020-08633.
    PubMed    


  13. RAUWERDINK DJW, Boland GM
    ASO Author Reflections: Adjuvant Treatment of Melanoma in the Modern Era.
    Ann Surg Oncol. 2020 May 28. pii: 10.1245/s10434-020-08671.
    PubMed    


  14. MONCRIEFF M, Heaton M
    ASO Author Reflections: Improved Perioperative Seroma and Complication Rates Following the Application of a Two-Layer Negative Pressure Wound Therapy System After Inguinal Lymphadenectomy for Metastatic Cutaneous Melanoma.
    Ann Surg Oncol. 2020 May 27. pii: 10.1245/s10434-020-08525.
    PubMed    


  15. RAUWERDINK DJW, Boland GM
    ASO Author Reflections: Mixed Response in Metastatic Melanoma Patients Treated with Immunotherapy.
    Ann Surg Oncol. 2020 May 26. pii: 10.1245/s10434-020-08663.
    PubMed    


  16. RAUWERDINK DJW, Molina G, Frederick DT, Sharova T, et al
    Adjuvant Therapy Failure Patterns in the Modern Era of Melanoma Management.
    Ann Surg Oncol. 2020 May 23. pii: 10.1245/s10434-020-08631.
    PubMed     Abstract available


  17. IBRAHIM AM, Le May M, Bosse D, Marginean H, et al
    Correction to: Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence.
    Ann Surg Oncol. 2020 May 22. pii: 10.1245/s10434-020-08618.
    PubMed     Abstract available


  18. SPILLANE AJ, Menzies AM, van Akkooi ACJ
    The Landmark Series: Neoadjuvant Systemic Therapy (NAST) for Stage 3 Melanoma Patients - A Potential Paradigm Shift in Management.
    Ann Surg Oncol. 2020 May 14. pii: 10.1245/s10434-020-08566.
    PubMed     Abstract available


  19. FARROW NE, Beasley GM
    ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy.
    Ann Surg Oncol. 2020 May 14. pii: 10.1245/s10434-020-08561.
    PubMed    


  20. VAN AKKOOI ACJ, Spillane AJ
    ASO Author Reflections: The Landmark Series: Neoadjuvant Systemic Therapy (NAST) for Stage 3 Melanoma Patients: A Potential Paradigm Shift in Management.
    Ann Surg Oncol. 2020 May 7. pii: 10.1245/s10434-020-08570.
    PubMed    


  21. IBRAHIM AM, Le May M, Bosse D, Marginean H, et al
    Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence.
    Ann Surg Oncol. 2020 May 3. pii: 10.1245/s10434-020-08407.
    PubMed     Abstract available


    April 2020
  22. FARROW NE, Raman V, Williams TP, Nguyen KY, et al
    Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy.
    Ann Surg Oncol. 2020 Apr 20. pii: 10.1245/s10434-020-08478.
    PubMed     Abstract available


  23. BEASLEY GM
    Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma.
    Ann Surg Oncol. 2020 Apr 19. pii: 10.1245/s10434-020-08460.
    PubMed    


  24. DE CARVALHO CEB, Capuzzo R, Crovador C, Teixeira RJ, et al
    Near Infrared (NIR) Fluorescence is Not a Substitute for Lymphoscintigraphy and Gamma Probe for Melanoma Sentinel Node Detection: Results from a Prospective Trial.
    Ann Surg Oncol. 2020 Apr 7. pii: 10.1245/s10434-020-08409.
    PubMed     Abstract available


  25. WEI X, Wu D, Li H, Zhang R, et al
    The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
    Ann Surg Oncol. 2020 Apr 6. pii: 10.1245/s10434-020-08418.
    PubMed     Abstract available


  26. AUSTIN J, Wright FC, Cheng SY, Sutradhar R, et al
    Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study.
    Ann Surg Oncol. 2020 Apr 4. pii: 10.1245/s10434-020-08265.
    PubMed     Abstract available


  27. WEI X, Si L, Guo J
    ASO Author Reflections: Primary Site Should Be Regarded as One Important Factor for Risk Stratification in Acral Melanoma.
    Ann Surg Oncol. 2020 Apr 4. pii: 10.1245/s10434-020-08420.
    PubMed    


  28. VAZQUEZ VL
    ASO Author Reflections: Near Infrared (NIR) Fluorescence is Not a Substitute for Lymphoscintigraphy and Gamma Probe for Melanoma Sentinel Node Detection: Results from a Prospective Trial.
    Ann Surg Oncol. 2020 Apr 2. pii: 10.1245/s10434-020-08410.
    PubMed    


    March 2020
  29. TERAS J, Kroon HM, Miura JT, Kenyon-Smith T, et al
    International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
    Ann Surg Oncol. 2020 Mar 9. pii: 10.1245/s10434-020-08312.
    PubMed     Abstract available


  30. TERAS J, Kroon HM, Zager JS
    ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and Effective.
    Ann Surg Oncol. 2020 Mar 6. pii: 10.1245/s10434-020-08314.
    PubMed    


    January 2020
  31. BELLO DM, Ariyan CE
    ASO Author Reflections: Is There a Re-invigorated Role for Melanoma Metastasectomy in a Checkpoint Blockade Era?
    Ann Surg Oncol. 2020 Jan 17. pii: 10.1245/s10434-020-08201.
    PubMed    


  32. SONG Y, Straker RJ 3rd, Xu X, Elder DE, et al
    Neoadjuvant Versus Adjuvant Immune Checkpoint Blockade in the Treatment of Clinical Stage III Melanoma.
    Ann Surg Oncol. 2020 Jan 2. pii: 10.1245/s10434-019-08174.
    PubMed     Abstract available


  33. BELLO DM, Faries MB
    The Landmark Series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes).
    Ann Surg Oncol. 2020;27:15-21.
    PubMed     Abstract available


    December 2019
  34. UPPAL A, Stern S, Thompson JF, Foshag L, et al
    Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
    Ann Surg Oncol. 2019 Dec 20. pii: 10.1245/s10434-019-08086.
    PubMed     Abstract available


  35. BELLO DM, Panageas KS, Hollmann T, Shoushtari AN, et al
    Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.
    Ann Surg Oncol. 2019 Dec 17. pii: 10.1245/s10434-019-08099.
    PubMed     Abstract available


  36. BELLO DM, Faries MB
    ASO Author Reflections: The Past, Present, and Future of Managing Melanoma Lymph Node Metastases: What the Trials Tell Us.
    Ann Surg Oncol. 2019 Dec 1. pii: 10.1245/s10434-019-08013.
    PubMed    


    November 2019
  37. KWAK JJ, Kesner AL, Gleisner A, Jensen A, et al
    Utility of Quantitative SPECT/CT Lymphoscintigraphy in Guiding Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
    Ann Surg Oncol. 2019 Nov 26. pii: 10.1245/s10434-019-08078.
    PubMed     Abstract available


    October 2019
  38. LIVINGSTONE A, Morton RL
    ASO Author Reflections: Important Factors for Adjuvant Immunotherapy Treatment Decisions for Stage II-IV Melanoma Patients and Their Clinicians.
    Ann Surg Oncol. 2019 Oct 31. pii: 10.1245/s10434-019-08020.
    PubMed    


  39. KWAK M, Song Y, Gimotty PA, Farrow NE, et al
    Correction to: Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis.
    Ann Surg Oncol. 2019 Oct 31. pii: 10.1245/s10434-019-08046.
    PubMed     Abstract available


  40. NIJHUIS AAG, Nieweg OE
    ASO Author Reflections: Melanoma Patients with a Local Recurrence or In-Transit Metastasis: Sentinel Node Biopsy to Identify Those at Highest Risk of Metastases and Death.
    Ann Surg Oncol. 2019 Oct 30. pii: 10.1245/s10434-019-08031.
    PubMed    


  41. LIVINGSTONE A, Agarwal A, Stockler MR, Menzies AM, et al
    Preferences for Immunotherapy in Melanoma: A Systematic Review.
    Ann Surg Oncol. 2019 Oct 29. pii: 10.1245/s10434-019-07963.
    PubMed     Abstract available


  42. ANGELES CV, Wong SL, Karakousis G
    ASO Author Reflections: Surgical Margins for Melanoma-What's Next?
    Ann Surg Oncol. 2019 Oct 25. pii: 10.1245/s10434-019-08015.
    PubMed    


  43. NAN TIE E, Na LH, Hicks RJ, Spillane J, et al
    The Prognosis and Natural History of In-Transit Melanoma Metastases at a High-Volume Centre.
    Ann Surg Oncol. 2019 Oct 22. pii: 10.1245/s10434-019-07965.
    PubMed     Abstract available


  44. SONG Y, Karakousis GC
    ASO Author Reflections: Survival for Stage III Melanoma-Where Do We Stand in the Current Landscape of Melanoma Therapies?
    Ann Surg Oncol. 2019 Oct 1. pii: 10.1245/s10434-019-07888.
    PubMed    


    September 2019
  45. THOMAS DC, Han D
    ASO Author Reflections: Recurrence of Melanoma After a Negative Sentinel Node Biopsy-Predictors and Impact of Recurrence Site on Survival.
    Ann Surg Oncol. 2019 Sep 30. pii: 10.1245/s10434-019-07889.
    PubMed    


  46. ANGELES CV, Wong SL, Karakousis G
    The Landmark Series: Randomized Trials Examining Surgical Margins for Cutaneous Melanoma.
    Ann Surg Oncol. 2019 Sep 27. pii: 10.1245/s10434-019-07866.
    PubMed     Abstract available


  47. LEE AY, Berman RS
    The Landmark Series: Non-melanoma Skin Cancers.
    Ann Surg Oncol. 2019 Sep 23. pii: 10.1245/s10434-019-07831.
    PubMed     Abstract available


  48. DECKERS EA, Hoekstra-Weebers JEHM, Damude S, Francken AB, et al
    The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB-IIC Patients-Results After 3 Years.
    Ann Surg Oncol. 2019 Sep 18. pii: 10.1245/s10434-019-07825.
    PubMed     Abstract available


  49. NELSON DW, Faries MB
    ASO Author Reflections: What Role Do Surgeons Play in the Era of Effective Systemic Therapy for Melanoma?
    Ann Surg Oncol. 2019 Sep 17. pii: 10.1245/s10434-019-07711.
    PubMed    


  50. EGGER ME, Scoggins CR, McMasters KM
    The Sunbelt Melanoma Trial.
    Ann Surg Oncol. 2019 Sep 16. pii: 10.1245/s10434-019-07828.
    PubMed     Abstract available


  51. HENDERSON MA, Gyorki D, Burmeister BH, Ainslie J, et al
    Inguinal and Ilio-inguinal Lymphadenectomy in Management of Palpable Melanoma Lymph Node Metastasis: A Long-Term Prospective Evaluation of Morbidity and Quality of Life.
    Ann Surg Oncol. 2019 Sep 12. pii: 10.1245/s10434-019-07810.
    PubMed     Abstract available


  52. EL SHAROUNI MA, Witkamp A, Sigurdsson V, van Diest PJ, et al
    ASO Author Reflections: Sentinel Lymph Node Biopsy Trend in Melanoma: The More the Merrier.
    Ann Surg Oncol. 2019 Sep 5. pii: 10.1245/s10434-019-07660.
    PubMed    


  53. SONG Y, Azari FS, Metzger DA, Fraker DL, et al
    Practice Patterns and Prognostic Value of Sentinel Lymph Node Biopsy for Thick Melanoma: A National Cancer Database Study.
    Ann Surg Oncol. 2019 Sep 4. pii: 10.1245/s10434-019-07783.
    PubMed     Abstract available


  54. FRANCKEN AB, Hoekstra-Weebers JEHM, Deckers E, Hoekstra HJ, et al
    ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified.
    Ann Surg Oncol. 2019 Sep 3. pii: 10.1245/s10434-019-07611.
    PubMed    


  55. MCKINLEY SK, Boland GM
    The Patient Speaks: Importance of Patient Perspectives in Clinical Decision-Making.
    Ann Surg Oncol. 2019;26:2665-2666.
    PubMed    


    August 2019
  56. BEASLEY GM, Zager JS, Thompson JF
    The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma.
    Ann Surg Oncol. 2019 Aug 30. pii: 10.1245/s10434-019-07760.
    PubMed     Abstract available


  57. LOWE MC, Delman KA
    A Call to Arms: Surgeons Must Play an Important and Early Role in the Management of Patients with Advanced Melanoma.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07648.
    PubMed    


  58. OLLILA DW, Meyers MO
    Time may Heal All Wounds, but While It Does, Melanoma Marches on.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07674.
    PubMed    


  59. KATSARELIAS D, Isaksson K, Olofsson Bagge R
    ASO Author Reflections: Effects of the Updated AJCC Classification for Patients with Stage III Melanoma.
    Ann Surg Oncol. 2019 Aug 29. pii: 10.1245/s10434-019-07765.
    PubMed    


  60. MASOUD SJ, Hu JB, Beasley GM, Stewart JH 4th, et al
    Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size.
    Ann Surg Oncol. 2019 Aug 14. pii: 10.1245/s10434-019-07691.
    PubMed     Abstract available


  61. NIJHUIS AAG, Santos Filho IDAO, Holtkamp LHJ, Uren RF, et al
    Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis.
    Ann Surg Oncol. 2019 Aug 12. pii: 10.1245/s10434-019-07699.
    PubMed     Abstract available


  62. BLOEMENDAL M, van Willigen WW, Bol KF, de Wilt JHW, et al
    ASO Author Reflections: Frequent Relapses Prior to the Start of Adjuvant Therapy in Stage IIIB/C Melanoma.
    Ann Surg Oncol. 2019 Aug 8. pii: 10.1245/s10434-019-07665.
    PubMed    


  63. KWAK M, Song Y, Gimotty PA, Farrow NE, et al
    Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis.
    Ann Surg Oncol. 2019 Aug 7. pii: 10.1245/s10434-019-07694.
    PubMed     Abstract available


  64. EGGER ME, Stevenson M, Bhutiani N, Jordan AC, et al
    Age and Lymphovascular Invasion Accurately Predict Sentinel Lymph Node Metastasis in T2 Melanoma Patients.
    Ann Surg Oncol. 2019 Aug 7. pii: 10.1245/s10434-019-07690.
    PubMed     Abstract available


    July 2019
  65. KNACKSTEDT R, Couto RA, Ko J, Cakmakoglu C, et al
    Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy for Sentinel Node Biopsy in Melanoma: Increasing the Sentinel Lymph Node-Positive Rate.
    Ann Surg Oncol. 2019 Jul 16. pii: 10.1245/s10434-019-07617.
    PubMed     Abstract available


  66. MIURA JT, Zager JS
    ASO Author Reflections: Robotic Pelvic Lymph Node Dissection for Metastatic Melanoma-A Minimally Invasive Approach to a Difficult Problem.
    Ann Surg Oncol. 2019 Jul 8. pii: 10.1245/s10434-019-07612.
    PubMed    


  67. SONG Y, Tieniber AD, Gimotty PA, Mitchell TC, et al
    Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies.
    Ann Surg Oncol. 2019 Jul 3. pii: 10.1245/s10434-019-07599.
    PubMed     Abstract available


    June 2019
  68. IPENBURG NA, Thompson JF, Uren RF, Chung D, et al
    Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients.
    Ann Surg Oncol. 2019 Jun 25. pii: 10.1245/s10434-019-07505.
    PubMed     Abstract available


  69. MAHVI DA, Fairweather M, Yoon CH, Cho NL, et al
    Utility of Level III Axillary Node Dissection in Melanoma Patients with Palpable Axillary Lymph Node Disease.
    Ann Surg Oncol. 2019 Jun 17. pii: 10.1245/s10434-019-07509.
    PubMed     Abstract available


  70. NELSON DW, Fischer TD, Graff-Baker AN, Dehal A, et al
    Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis.
    Ann Surg Oncol. 2019 Jun 10. pii: 10.1245/s10434-019-07487.
    PubMed     Abstract available


    May 2019
  71. ISAKSSON K, Katsarelias D, Mikiver R, Carneiro A, et al
    A Population-Based Comparison of the AJCC 7th and AJCC 8th Editions for Patients Diagnosed with Stage III Cutaneous Malignant Melanoma in Sweden.
    Ann Surg Oncol. 2019 May 20. pii: 10.1245/s10434-019-07448.
    PubMed     Abstract available


  72. MIURA JT, Kroon HM, Zager JS
    ASO Author Reflections: International Experience of Isolated Limb Infusion for Melanoma Shows Durable Response.
    Ann Surg Oncol. 2019 May 13. pii: 10.1245/s10434-019-07435.
    PubMed    


  73. KARAKOUSIS GC
    Let's Not Forget About Regional Therapy for the Treatment of Locally Advanced Extremity Melanoma.
    Ann Surg Oncol. 2019 May 6. pii: 10.1245/s10434-019-07430.
    PubMed    


    April 2019
  74. THOMAS DC, Han G, Leong SP, Kashani-Sabet M, et al
    Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival.
    Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07369.
    PubMed     Abstract available


  75. BANTING S, Milne D, Thorpe T, Na L, et al
    Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient's Perspective.
    Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07375.
    PubMed     Abstract available


  76. MIURA JT, Dossett LA, Thapa R, Kim Y, et al
    Robotic-Assisted Pelvic Lymphadenectomy for Metastatic Melanoma Results in Durable Oncologic Outcomes.
    Ann Surg Oncol. 2019 Apr 4. pii: 10.1245/s10434-019-07333.
    PubMed     Abstract available


    March 2019
  77. MIURA JT, Kroon HM, Beasley GM, Mullen D, et al
    Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
    Ann Surg Oncol. 2019 Mar 25. pii: 10.1245/s10434-019-07288.
    PubMed     Abstract available


  78. NIJHUIS AAG, Dieng M, Khanna N, Lord SJ, et al
    False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma.
    Ann Surg Oncol. 2019 Mar 25. pii: 10.1245/s10434-019-07311.
    PubMed     Abstract available


  79. BLOEMENDAL M, van Willigen WW, Bol KF, Boers-Sonderen MJ, et al
    Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy.
    Ann Surg Oncol. 2019 Mar 4. pii: 10.1245/s10434-019-07274.
    PubMed     Abstract available


    February 2019
  80. LEONG SP, Wu M, Lu Y, Torre DM, et al
    Correction to: Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery.
    Ann Surg Oncol. 2019 Feb 25. pii: 10.1245/s10434-019-07233.
    PubMed     Abstract available


  81. BERMAN RS, Gershenwald JE
    Completion Node Dissection for Sentinel Node-Positive Melanoma: Can a Systematic Review Bring One Discussion to a Close While Leaving the Broader Conversation Still Open?
    Ann Surg Oncol. 2019 Feb 8. pii: 10.1245/s10434-019-07211.
    PubMed    


  82. CHAKERA AH, Thompson JF
    ASO Author Reflections: Subungual Melanomas of the Hand Present Diagnostic and Therapeutic Challenges.
    Ann Surg Oncol. 2019 Feb 4. pii: 10.1245/s10434-019-07196.
    PubMed    


  83. EL SHAROUNI MA, Witkamp AJ, Sigurdsson V, van Diest PJ, et al
    Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma.
    Ann Surg Oncol. 2019 Feb 4. pii: 10.1245/s10434-019-07204.
    PubMed     Abstract available


    January 2019
  84. KING BBT, Chapman BC, Gleisner A, Stewart C, et al
    Postbiopsy Pigmentation is Prognostic in Head and Neck Melanoma.
    Ann Surg Oncol. 2019 Jan 31. pii: 10.1245/s10434-019-07185.
    PubMed     Abstract available


  85. TRINH BB, Kounalakis N
    ASO Author Reflections: Impact of SPECT/CT on Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
    Ann Surg Oncol. 2019 Jan 11. pii: 10.1245/s10434-018-6955.
    PubMed    


  86. BELGRANO V, Pettersson J, Nilsson JA, Mattsson J, et al
    Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma.
    Ann Surg Oncol. 2019 Jan 7. pii: 10.1245/s10434-018-07143.
    PubMed     Abstract available


    December 2018
  87. CHAKERA AH, Quinn MJ, Lo S, Drummond M, et al
    Subungual Melanoma of the Hand.
    Ann Surg Oncol. 2018 Dec 18. pii: 10.1245/s10434-018-07094.
    PubMed     Abstract available


  88. NESSIM C, Crawford AB
    ASO Author Reflections: Wait Times for Melanoma Surgery.
    Ann Surg Oncol. 2018 Dec 4. pii: 10.1245/s10434-018-7022.
    PubMed    


    November 2018
  89. KROON HM, Thompson JF
    Isolated Limb Infusion and Isolated Limb Perfusion for Melanoma: Can the Outcomes of these Procedures be Compared?
    Ann Surg Oncol. 2018 Nov 21. pii: 10.1245/s10434-018-7067.
    PubMed    


  90. BERTOLLI E, Franke V, Calsavara VF, de Macedo MP, et al
    Validation of a Nomogram for Non-sentinel Node Positivity in Melanoma Patients, and Its Clinical Implications: A Brazilian-Dutch Study.
    Ann Surg Oncol. 2018 Nov 19. pii: 10.1245/s10434-018-7038.
    PubMed     Abstract available


  91. KARAKOUSIS GC, Gimotty PA, Leong SP, Pockaj BA, et al
    Microsatellitosis in Patients with Melanoma.
    Ann Surg Oncol. 2018 Nov 12. pii: 10.1245/s10434-018-7006.
    PubMed     Abstract available


  92. THOMPSON JF, Scolyer RA, Lo SN
    ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas.
    Ann Surg Oncol. 2018 Nov 9. pii: 10.1245/s10434-018-7014.
    PubMed    


  93. YOUNG CJ
    ASO Author Reflections: Metastatic Melanoma to the Large Bowel.
    Ann Surg Oncol. 2018 Nov 7. pii: 10.1245/s10434-018-6972.
    PubMed    


  94. CHAKEDIS J, Phay JE
    ASO Author Reflections: Identification of the Thoracic Duct using Indocyanine Green During Cervical Lymphadenectomy.
    Ann Surg Oncol. 2018;25:3718.
    PubMed    


  95. CHAKEDIS J, Shirley LA, Terando AM, Skoracki R, et al
    Identification of the Thoracic Duct Using Indocyanine Green During Cervical Lymphadenectomy.
    Ann Surg Oncol. 2018;25:3711-3717.
    PubMed     Abstract available


    October 2018
  96. THOMPSON JF, Kroon HM
    ASO Author Reflections: Limited Surgery Plus Radiotherapy for Melanoma Patients with Cervical Node Metastases.
    Ann Surg Oncol. 2018 Oct 26. pii: 10.1245/s10434-018-6959.
    PubMed    


  97. FRIEDMAN EB, Dodds TJ, Lo S, Ferguson PM, et al
    Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens.
    Ann Surg Oncol. 2018 Oct 16. pii: 10.1245/s10434-018-6858.
    PubMed     Abstract available


  98. ROBINSON AV, Peach H, Wade RG
    ASO Author Reflections: Hematological Biomarkers of Survival in Cutaneous Melanoma.
    Ann Surg Oncol. 2018 Oct 15. pii: 10.1245/s10434-018-6913.
    PubMed    


  99. EGGER ME, McMasters KM
    ASO Author Reflections: The Sentinel Lymph Node in Melanoma: Now More Important Than Ever.
    Ann Surg Oncol. 2018 Oct 11. pii: 10.1245/s10434-018-6855.
    PubMed    


  100. MURTHA TD, Han D
    ASO Author Reflections: Factors that Predict Performance of Sentinel Lymph Node Biopsy and the Association with Improved Survival for Melanoma Patients Who Have Nodal Staging.
    Ann Surg Oncol. 2018 Oct 9. pii: 10.1245/s10434-018-6841.
    PubMed    


  101. LOWE MC, Farley CR, Delman KA
    ASO Author Reflections: Optimizing the Outcomes for Patients: The Evolution of the Management of Regional Disease in Patients with Melanoma.
    Ann Surg Oncol. 2018 Oct 8. pii: 10.1245/s10434-018-6857.
    PubMed    


  102. PEREZ MC, Miura JT, Naqvi SMH, Kim Y, et al
    Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience.
    Ann Surg Oncol. 2018 Oct 8. pii: 10.1245/s10434-018-6803.
    PubMed     Abstract available


  103. HIEKEN TJ, Kane JM 3rd, Wong SL
    The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma.
    Ann Surg Oncol. 2018 Oct 3. pii: 10.1245/s10434-018-6812.
    PubMed     Abstract available


    September 2018
  104. AMIT M, Hanna EY
    ASO Author Reflections: Treatment Approaches to Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Sep 28. pii: 10.1245/s10434-018-6815.
    PubMed    


  105. LEE JS, Howard RA, Klueh MP, Englesbe MJ, et al
    The Impact of Education and Prescribing Guidelines on Opioid Prescribing for Breast and Melanoma Procedures.
    Ann Surg Oncol. 2018 Sep 20. pii: 10.1245/s10434-018-6772.
    PubMed     Abstract available


  106. LEONG SP
    The Intraoperative Portable Gamma Camera Is an Important Adjunct to the Gamma Probe in Identifying Melanoma Sentinel Lymph Nodes.
    Ann Surg Oncol. 2018 Sep 14. pii: 10.1245/s10434-018-6755.
    PubMed    


  107. FIELDS AC, Goldberg J, Senturk J, Saadat LV, et al
    Contemporary Surgical Management and Outcomes for Anal Melanoma: A National Cancer Database Analysis.
    Ann Surg Oncol. 2018 Sep 12. pii: 10.1245/s10434-018-6769.
    PubMed     Abstract available


  108. RAND JG, Faries MB
    Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed.
    Ann Surg Oncol. 2018 Sep 12. pii: 10.1245/s10434-018-6744.
    PubMed    


  109. COIT D, Ariyan C
    MelMART Trial: It's Now or Never.
    Ann Surg Oncol. 2018;25:2493-2495.
    PubMed    


    August 2018
  110. KROON HM, van der Bol WD, Tonks KT, Hong AM, et al
    Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities.
    Ann Surg Oncol. 2018 Aug 16. pii: 10.1245/s10434-018-6692.
    PubMed     Abstract available


  111. GERSHENWALD JE, Scolyer RA
    Correction to: Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
    Ann Surg Oncol. 2018 Aug 13. pii: 10.1245/s10434-018-6689.
    PubMed     Abstract available


  112. LEONG SP, Wu M, Lu Y, Torre DM, et al
    Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery.
    Ann Surg Oncol. 2018 Aug 13. pii: 10.1245/s10434-018-6685.
    PubMed     Abstract available


    July 2018
  113. WADE RG, Robinson AV, Lo MCI, Keeble C, et al
    Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study.
    Ann Surg Oncol. 2018 Jul 31. pii: 10.1245/s10434-018-6660.
    PubMed     Abstract available


  114. SINNAMON AJ, Song Y, Sharon CE, Yang YX, et al
    Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Ann Surg Oncol. 2018 Jul 24. pii: 10.1245/s10434-018-6647.
    PubMed     Abstract available


  115. COLLICHIO F, Burke L, Proctor A, Wallack D, et al
    Implementing a Program of Talimogene laherparepvec.
    Ann Surg Oncol. 2018;25:1828-1835.
    PubMed     Abstract available


    June 2018
  116. MONCRIEFF MD, Gyorki D, Saw R, Spillane AJ, et al
    Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
    Ann Surg Oncol. 2018 Jun 26. pii: 10.1245/s10434-018-6612.
    PubMed     Abstract available


  117. SIBLEY R, Subramaniam RM
    SPECT/CT: Looking Beyond Sentinel Lymph Node Identification for Improving Patient Outcomes.
    Ann Surg Oncol. 2018;25:1467-1468.
    PubMed    


    May 2018
  118. MONCRIEFF MD, Gyorki D, Saw R, Spillane AJ, et al
    1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
    Ann Surg Oncol. 2018 May 30. pii: 10.1245/s10434-018-6470.
    PubMed     Abstract available


  119. GERSHENWALD JE, Scolyer RA
    Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
    Ann Surg Oncol. 2018 May 30. pii: 10.1245/s10434-018-6513.
    PubMed    


  120. KATSARELIAS D, Radbo E, Ben-Shabat I, Mattsson J, et al
    The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Ann Surg Oncol. 2018 May 15. pii: 10.1245/s10434-018-6459.
    PubMed     Abstract available


  121. BALCH CM
    Revolutionary Advances in Immunotherapy for Melanoma Are Coming into the Surgical Arena: Are We Ready?
    Ann Surg Oncol. 2018 May 11. pii: 10.1245/s10434-018-6516.
    PubMed    


  122. CUI C, Lian B, Zhou L, Song X, et al
    Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.
    Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6503.
    PubMed     Abstract available


    April 2018
  123. PARK JS, Ng KS, Saw RPM, Thompson JF, et al
    Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience.
    Ann Surg Oncol. 2018 Apr 24. pii: 10.1245/s10434-018-6451.
    PubMed     Abstract available


  124. AMIT M, Tam S, Abdelmeguid AS, Kupferman ME, et al
    Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Apr 6. pii: 10.1245/s10434-018-6465.
    PubMed     Abstract available


    March 2018
  125. EGGER ME, Xiao D, Hao H, Kimbrough CW, et al
    Unique Genes in Tumor-Positive Sentinel Lymph Nodes Associated with Nonsentinel Lymph Node Metastases in Melanoma.
    Ann Surg Oncol. 2018 Mar 1. pii: 10.1245/s10434-018-6377.
    PubMed     Abstract available


    February 2018
  126. ZABOR EC, Coit D, Gershenwald JE, McMasters KM, et al
    Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors.
    Ann Surg Oncol. 2018 Feb 22. pii: 10.1245/s10434-018-6370.
    PubMed     Abstract available


  127. BELLO DM, Ariyan CE
    Adjuvant Therapy in the Treatment of Melanoma.
    Ann Surg Oncol. 2018 Feb 21. pii: 10.1245/s10434-018-6376.
    PubMed    


    January 2018
  128. MURTHA TD, Han G, Han D
    Predictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients Who Have Nodal Staging.
    Ann Surg Oncol. 2018 Jan 24. pii: 10.1245/s10434-018-6348.
    PubMed     Abstract available


  129. TRINH BB, Chapman BC, Gleisner A, Kwak JJ, et al
    SPECT/CT Adds Distinct Lymph Node Basins and Influences Radiologic Findings and Surgical Approach for Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
    Ann Surg Oncol. 2018 Jan 12. pii: 10.1245/s10434-017-6298.
    PubMed     Abstract available


  130. LO SN, Scolyer RA, Thompson JF
    Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.
    Ann Surg Oncol. 2018 Jan 12. pii: 10.1245/s10434-017-6325.
    PubMed     Abstract available


  131. FARIES MB
    Completing the Dissection in Melanoma: Increasing Decision Precision.
    Ann Surg Oncol. 2018 Jan 4. pii: 10.1245/s10434-017-6330.
    PubMed    


  132. READ RL, Madronio CM, Cust AE, Goumas C, et al
    Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia.
    Ann Surg Oncol. 2018 Jan 3. pii: 10.1245/s10434-017-6319.
    PubMed     Abstract available


  133. SHIRAI K, Wong SL
    Melanoma Surveillance Strategies: Different Approaches to a Shared Goal.
    Ann Surg Oncol. 2018 Jan 2. pii: 10.1245/s10434-017-6321.
    PubMed    


    December 2017
  134. LI S, Sheng X, Si L, Cui C, et al
    Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.
    Ann Surg Oncol. 2017 Dec 21. pii: 10.1245/s10434-017-6256.
    PubMed     Abstract available


  135. WONG SL, Faries MB, Kennedy EB, Agarwala SS, et al
    Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Ann Surg Oncol. 2017 Dec 13. pii: 10.1245/s10434-017-6267.
    PubMed     Abstract available


    November 2017
  136. POSTLEWAIT LM, Farley CR, Seamens AM, Le N, et al
    Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6242.
    PubMed     Abstract available


  137. VOIT CA, van Akkooi ACJ, Catalano O, Eggermont AMM, et al
    Pre-SN Ultrasound-FNAC can be Sensitive for Lymph Node Metastases in Melanoma Patients if Performed with the Use of the Berlin Criteria.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6230.
    PubMed    


  138. CHAI C, Szabunio M, Cook C, Zager J, et al
    Pre-SN Ultrasound-FNAC for Lymph Node Metastases in Melanoma Patients: A Reply.
    Ann Surg Oncol. 2017 Nov 13. doi: 10.1245/s10434-017-6231.
    PubMed    


  139. MADU MF, van de Wiel B, van Akkooi ACJ
    Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6169.
    PubMed    


  140. CRAWFORD AB, Nessim C, Weaver J, van Walraven C, et al
    Wait Times for Melanoma Surgery: Is There an Association with Overall Survival?
    Ann Surg Oncol. 2017 Nov 3. doi: 10.1245/s10434-017-6146.
    PubMed     Abstract available


    October 2017
  141. HOLTKAMP LHJ, Wang S, Wilmott JS, Madore J, et al
    Reply to comment on: Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2017 Oct 27. doi: 10.1245/s10434-017-6170.
    PubMed    


  142. ROSSI CR, Mocellin S, Campana LG, Borgognoni L, et al
    Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
    Ann Surg Oncol. 2017 Oct 24. doi: 10.1245/s10434-017-6143.
    PubMed     Abstract available


  143. FARIES MB, Mozzillo N, Kashani-Sabet M, Thompson JF, et al
    Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
    Ann Surg Oncol. 2017 Oct 10. doi: 10.1245/s10434-017-6072.
    PubMed     Abstract available


    August 2017
  144. KROON HM, Coventry BJ, Giles MH, Henderson MA, et al
    Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study.
    Ann Surg Oncol. 2017 Aug 10. doi: 10.1245/s10434-017-6046.
    PubMed     Abstract available


  145. POSTLEWAIT LM, Farley CR, Diller ML, Martin B, et al
    A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial.
    Ann Surg Oncol. 2017 Aug 2. doi: 10.1245/s10434-017-5971.
    PubMed     Abstract available


    May 2017
  146. VAREY AHR, Madronio CM, Cust AE, Goumas C, et al
    Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia.
    Ann Surg Oncol. 2017 May 25. doi: 10.1245/s10434-017-5890.
    PubMed     Abstract available


  147. KANG R, Wong SL
    Melanoma Surgery: Why Don't We Let the Guidelines Guide Practice?
    Ann Surg Oncol. 2017 May 22. doi: 10.1245/s10434-017-5891.
    PubMed    


  148. BEASLEY GM, Hu Y, Youngwirth L, Scheri RP, et al
    Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.
    Ann Surg Oncol. 2017 May 15. doi: 10.1245/s10434-017-5883.
    PubMed     Abstract available


    April 2017
  149. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
    Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Ann Surg Oncol. 2017;24:906-913.
    PubMed     Abstract available


    March 2017
  150. MORTON RL, Tran A, Vessey JY, Rowbotham N, et al
    Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications.
    Ann Surg Oncol. 2017 Mar 20. doi: 10.1245/s10434-017-5842.
    PubMed     Abstract available


  151. DAVIS JL, Langan RC, Panageas KS, Zheng J, et al
    Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
    Ann Surg Oncol. 2017 Mar 16. doi: 10.1245/s10434-017-5836.
    PubMed     Abstract available


    February 2017
  152. JONES MS, Jones PC, Stern SL, Elashoff D, et al
    The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.
    Ann Surg Oncol. 2017 Feb 21. doi: 10.1245/s10434-017-5775.
    PubMed     Abstract available


  153. MADU MF, Deken MM, van der Hage JA, Jozwiak K, et al
    Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.
    Ann Surg Oncol. 2017 Feb 10. doi: 10.1245/s10434-017-5803.
    PubMed     Abstract available


  154. DOEPKER MP, Yamamoto M, Applebaum MA, Patel NU, et al
    Comparison of Single-Photon Emission Computed Tomography-Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies.
    Ann Surg Oncol. 2017;24:355-361.
    PubMed     Abstract available


  155. FAUT M, Heidema RM, Hoekstra HJ, van Ginkel RJ, et al
    Morbidity After Inguinal Lymph Node Dissections: It Is Time for a Change.
    Ann Surg Oncol. 2017;24:330-339.
    PubMed     Abstract available


  156. LATCHANA N, Del Campo SE, Grignol VP, Clark JR, et al
    Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Ann Surg Oncol. 2017;24:347-354.
    PubMed     Abstract available


    January 2017
  157. PARK TS, Phan GQ, Yang JC, Kammula U, et al
    Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 31. doi: 10.1245/s10434-017-5768.
    PubMed     Abstract available


  158. CROOKES TR, Scolyer RA, Lo S, Drummond M, et al
    Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 27. doi: 10.1245/s10434-016-5723.
    PubMed     Abstract available


  159. BHUTIANI N, Egger ME, McMasters KM
    Optimizing Follow-up Assessment of Patients with Cutaneous Melanoma.
    Ann Surg Oncol. 2017 Jan 24. doi: 10.1245/s10434-017-5771.
    PubMed    


  160. STEWART CL, Gleisner A, Kwak J, Chapman B, et al
    Implications of Sentinel Lymph Node Drainage to Multiple Basins in Head and Neck Melanoma.
    Ann Surg Oncol. 2017 Jan 5. doi: 10.1245/s10434-016-5744.
    PubMed     Abstract available


    November 2016
  161. KARAKOUSIS G, Gimotty PA, Bartlett EK, Sim MS, et al
    Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


  162. LEE AY, Droppelmann N, Panageas KS, Zhou Q, et al
    Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


    September 2016
  163. HAO H, Xiao D, Pan J, Qu J, et al
    Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


  164. FAUT M, Wevers KP, van Ginkel RJ, Diercks GF, et al
    Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


  165. KLEMEN ND, Feingold PL, Goff SL, Hughes MS, et al
    Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Abstract available


  166. ENGELHARDT KE, Wayne JD, Bilimoria KY
    Editorial: Should We Abandon TNM Staging in Favor of Gene Profiles in Node-Positive Melanoma?
    Ann Surg Oncol. 2016.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: